Prognostic significance of early ischemia after acute myocardial infarction in low-risk patients. IRES (Ischemia Residua) Study Group.
暂无分享,去创建一个
[1] R. Califf,et al. Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.
[2] W. Rogers,et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.
[3] M. Stadius,et al. Coronary artery revascularization. Critical need for, and consequences of, objective angiographic assessment of lesion severity. , 1990, Circulation.
[4] M. Motro,et al. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. , 1990, The American journal of cardiology.
[5] R. Califf,et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.
[6] E. Braunwald,et al. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.
[7] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.
[8] A. Moss,et al. Prognosis and management after a first myocardial infarction. , 1990, The New England journal of medicine.
[9] David Oakes,et al. Prognostic significance of nonfatal myocardial reinfarction , 1990 .
[10] J. O’Meara,et al. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. , 1990, The American journal of cardiology.
[11] P. Teirstein,et al. Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. , 1990, Journal of the American College of Cardiology.
[12] M. Gheorghiade,et al. Cardiac event rate after non-Q-wave acute myocardial infarction and the significance of its anterior location. , 1989, The American journal of cardiology.
[13] C. White. Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy. , 1989, Circulation.
[14] K. Lee,et al. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. , 1989, Circulation.
[15] E. Gilpin,et al. A decision scheme for coronary angiography after acute myocardial infarction. , 1989, Circulation.
[16] L. Tavazzi,et al. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction , 1989 .
[17] A. Moss,et al. Occurrence, characteristics and prognostic significance of early postacute myocardial infarction angina pectoris. , 1988, The American journal of cardiology.
[18] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[19] H. White,et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.
[20] A. Ross,et al. Reinfarction, recurrent angina, and reocclusion after thrombolytic therapy. , 1987, Circulation.
[21] R. W. Brower,et al. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate. , 1987, The American journal of cardiology.
[22] D. Waters,et al. Early postinfarction ischemia: clinical, angiographic, and prognostic significance. , 1987, Circulation.
[23] R. W. Brower,et al. Early post-infarction angina. Incidence and prognostic relevance. , 1986, European heart journal.
[24] J. Bigger. Angina pectoris early after myocardial infarction: clinical experience of the multicentre post-infarction program. , 1986, European heart journal.
[25] M. Gheorghiade,et al. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study. , 1986, Circulation.
[26] P. Serruys,et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.
[27] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[28] I. Palacios,et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.
[29] K. Karsch,et al. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. , 1984, The New England journal of medicine.
[30] A. Ross,et al. A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. , 1984, The American journal of cardiology.
[31] B. Bulkley,et al. Early post-infarction angina. Ischemia at a distance and ischemia in the infarct zone. , 1981, The New England journal of medicine.
[32] B. Sobel,et al. Factors presaging early recurrent myocardial infarction ("extension"). , 1981, The American journal of cardiology.
[33] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[34] Barr Jb,et al. HOME OR AWAY? , 1964, Lancet.